Tivozanib: Phase Ib data

Data from 17 evaluable patients in an open-label, dose-escalation Phase Ib trial showed that once-daily oral tivozanib plus FOLFOX6 (5-FU, leucovorin, and oxaliplatin) chemotherapy produced 6 partial ...